Eagle Pharmaceuticals, Inc.
EGRX
$1.90
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -29.88% | -60.42% | 259.60% | -57.92% | -47.41% |
| Total Receivables | 0.16% | 58.69% | -26.03% | 5.21% | -31.97% |
| Inventory | -3.76% | -7.65% | -25.15% | 10.64% | 132.54% |
| Prepaid Expenses | -32.21% | -3.45% | 510.80% | -72.28% | 1.68% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 45.51% | -15.99% | 35.15% | 42.14% | -27.14% |
| Total Current Assets | -2.72% | 1.98% | 2.00% | -4.84% | -19.03% |
|
|
|||||
| Total Current Assets | -2.72% | 1.98% | 2.00% | -4.84% | -19.03% |
| Net Property, Plant & Equipment | -9.23% | -4.45% | -9.95% | -11.10% | -10.33% |
| Long-term Investments | 0.00% | 0.00% | 7.75% | -2.93% | 8.34% |
| Goodwill | 0.00% | 0.00% | 7.75% | -2.93% | 8.34% |
| Total Other Intangibles | -4.52% | -4.31% | 8.16% | 3.94% | 1,031.53% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.43% | 4.81% | 15.49% | 9.35% | 9.21% |
| Total Assets | -2.26% | 1.97% | 5.10% | 1.23% | 19.24% |
|
|
|||||
| Total Accounts Payable | -7.39% | -9.92% | 43.72% | -33.83% | 37.65% |
| Total Accrued Expenses | 4.83% | -18.91% | 41.10% | -0.34% | 2.31% |
| Short-term Debt | 10.63% | 20.00% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.40% | 3.46% | -95.79% | 56.39% | -6.95% |
| Total Finance Division Other Current Liabilities | -78.50% | 0.52% | -31.03% | 37.66% | 16.69% |
| Total Other Current Liabilities | -78.50% | 0.52% | -31.03% | 37.66% | 16.69% |
| Total Current Liabilities | -11.43% | -11.95% | -8.82% | 11.81% | 7.20% |
|
|
|||||
| Total Current Liabilities | -11.43% | -11.95% | -8.82% | 11.81% | 7.20% |
| Long-Term Debt | -10.07% | 22.44% | 112.69% | -5.66% | -- |
| Short-term Debt | 10.63% | 20.00% | -- | -- | -- |
| Capital Leases | -20.47% | -30.04% | -19.53% | -16.93% | -11.98% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -6.05% | -4.01% | -16.47% | 0.00% | -- |
| Total Liabilities | -10.83% | -0.74% | 11.59% | 7.58% | 37.97% |
|
|
|||||
| Common Stock & APIC | 1.09% | 0.97% | 1.13% | 1.06% | 9.01% |
| Retained Earnings | 4.40% | 5.16% | 7.90% | -6.46% | -7.88% |
| Treasury Stock & Other | 0.00% | 0.00% | -4.49% | -1.24% | 0.80% |
| Total Common Equity | 3.79% | 3.98% | 0.77% | -2.61% | 10.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.79% | 3.98% | 0.77% | -2.61% | 10.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.79% | 3.98% | 0.77% | -2.61% | 10.20% |
|
|
|||||